• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在过去的二十年中,日本的高密度脂蛋白水平显著升高。

High-density lipoprotein levels have markedly increased over the past twenty years in Japan.

机构信息

Nutritional Health Science Research Center, Chubu University.

出版信息

J Atheroscler Thromb. 2014;21(2):151-60. doi: 10.5551/jat.20909. Epub 2013 Oct 7.

DOI:10.5551/jat.20909
PMID:24096936
Abstract

AIM

The high-density lipoprotein cholesterol(HDL-C) level is a major negative risk factor for atherosclerotic diseases dependent on various lifestyle parameters. Changes in the lifestyle of Japanese individuals over the past several decades is believed to have increased their total cholesterol levels and the incidence of cardiovascular disease in Japan. It is therefore important to assess the long-term trends in the HDL-C levels with respect to public health in the community.

METHODS

In this study, accumulated data for the serum/plasma HDL-C levels published in cohort studies and obtained during health checkup programs in Japan were analyzed with respect to timedependent changes.

RESULTS

The levels of HDL-C have continuously and significantly increased over the past 20 years by 12-15% according to the National Health and Nutrition Study, other cohort studies and commercially available data. On the other hand, the non-HDL-cholesterol levels demonstrated no changes or only a slight decrease during the same period. This finding is consistent with several sets of data obtained from health checkup programs. The commercially measured levels of serum apoA-I, an independent parameter of serum HDL, also showed a similar long-term increase, supporting the above findings.

CONCLUSION

We concluded that the serum/plasma HDL concentrations in Japanese individuals, selectively, have increased continuously and significantly over the past 20 years or more. The reasons for this phenomenon and the consequent public health outcomes have yet to be investigated.

摘要

目的

高密度脂蛋白胆固醇(HDL-C)水平是依赖于多种生活方式参数的动脉粥样硬化疾病的主要负风险因素。过去几十年,日本人的生活方式发生了变化,据信这增加了他们的总胆固醇水平和日本心血管疾病的发病率。因此,评估社区公共卫生中 HDL-C 水平的长期趋势非常重要。

方法

在这项研究中,分析了日本队列研究中发表的关于血清/血浆 HDL-C 水平的累积数据,并根据时间依赖性变化进行了分析。

结果

根据国家健康和营养调查、其他队列研究和商业可用数据,过去 20 年来,HDL-C 水平持续显著升高了 12-15%。另一方面,在同一时期,非高密度脂蛋白胆固醇水平没有变化或仅略有下降。这一发现与从健康检查计划中获得的几组数据一致。商业测量的血清载脂蛋白 A-I 水平(血清 HDL 的独立参数)也显示出类似的长期升高,支持了上述发现。

结论

我们得出结论,过去 20 年或更长时间以来,日本人的血清/血浆 HDL 浓度选择性地持续显著升高。这种现象的原因和随之而来的公共卫生后果还有待研究。

相似文献

1
High-density lipoprotein levels have markedly increased over the past twenty years in Japan.在过去的二十年中,日本的高密度脂蛋白水平显著升高。
J Atheroscler Thromb. 2014;21(2):151-60. doi: 10.5551/jat.20909. Epub 2013 Oct 7.
2
High-density lipoprotein cholesterol, high-density lipoprotein particle size, and apolipoprotein A-I: significance for cardiovascular risk: the IDEAL and EPIC-Norfolk studies.高密度脂蛋白胆固醇、高密度脂蛋白颗粒大小及载脂蛋白A-I:对心血管风险的意义:IDEAL研究与EPIC-诺福克研究
J Am Coll Cardiol. 2008 Feb 12;51(6):634-42. doi: 10.1016/j.jacc.2007.09.060.
3
Optimal therapy of low levels of high density lipoprotein-cholesterol.高密度脂蛋白胆固醇水平偏低的最佳治疗方法。
Am J Cardiovasc Drugs. 2003;3(1):53-65. doi: 10.2165/00129784-200303010-00006.
4
HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.HMG-CoA 还原酶抑制剂(他汀类药物)治疗与日本人群的冠状动脉粥样硬化:高密度脂蛋白胆固醇的作用。
Am J Cardiovasc Drugs. 2011 Dec 1;11(6):411-7. doi: 10.2165/11594620-000000000-00000.
5
Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.碳水化合物、脂质和载脂蛋白代谢的血液生物标志物与肌萎缩侧索硬化症的风险:对瑞典 AMORIS 队列超过 20 年的随访。
Ann Neurol. 2017 May;81(5):718-728. doi: 10.1002/ana.24936.
6
Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.他汀类药物治疗患者中高密度脂蛋白胆固醇与载脂蛋白A-I比值与冠状动脉粥样硬化进展的关系。
Am J Cardiol. 2014 Sep 1;114(5):681-5. doi: 10.1016/j.amjcard.2014.06.001. Epub 2014 Jun 18.
7
A pooled analysis of the association of isolated low levels of high-density lipoprotein cholesterol with cardiovascular mortality in Japan.一项荟萃分析显示,日本孤立性低高密度脂蛋白胆固醇水平与心血管死亡率之间存在关联。
Eur J Epidemiol. 2017 Jul;32(7):547-557. doi: 10.1007/s10654-016-0203-1. Epub 2016 Oct 5.
8
Pitavastatin: novel effects on lipid parameters.匹伐他汀:对血脂参数的新作用。
Atheroscler Suppl. 2011 Nov;12(3):277-84. doi: 10.1016/S1567-5688(11)70887-X.
9
Common variation in cholesteryl ester transfer protein: relationship of first major adverse cardiovascular events with the apolipoprotein B/apolipoprotein A-I ratio and the total cholesterol/high-density lipoprotein cholesterol ratio.胆固醇酯转移蛋白的常见变异:载脂蛋白 B/载脂蛋白 A-I 比值和总胆固醇/高密度脂蛋白胆固醇比值与首次主要心血管不良事件的关系。
J Clin Lipidol. 2013 Jan-Feb;7(1):56-64. doi: 10.1016/j.jacl.2012.05.003. Epub 2012 May 22.
10
Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.美国接受他汀类药物治疗成年人中根据低密度脂蛋白胆固醇、非高密度脂蛋白胆固醇和载脂蛋白B划分的残余血脂异常:2009 - 2010年美国国家健康和营养检查调查
J Clin Lipidol. 2015 Jul-Aug;9(4):525-32. doi: 10.1016/j.jacl.2015.05.003. Epub 2015 May 16.

引用本文的文献

1
What is the Cause of Continuous and Marked Increase of Japanese High Density Lipoprotein Cholesterol?日本高密度脂蛋白胆固醇持续显著升高的原因是什么?
J Atheroscler Thromb. 2023 Aug 1;30(8):861-862. doi: 10.5551/jat.ED223. Epub 2023 Jan 26.
2
Continuous and Marked Increase of Japanese HDL Associates Paradoxically with their Nutritional Shift.日本高密度脂蛋白(HDL)持续且显著增加与他们的营养结构转变有关,这构成了一个悖论。
J Atheroscler Thromb. 2023 Aug 1;30(8):919-933. doi: 10.5551/jat.63894. Epub 2022 Nov 15.
3
Hyperalphalipoproteinemia and Beyond: The Role of HDL in Cardiovascular Diseases.
高α脂蛋白血症及其他:高密度脂蛋白在心血管疾病中的作用
Life (Basel). 2021 Jun 18;11(6):581. doi: 10.3390/life11060581.
4
Association between extremely high high-density lipoprotein-cholesterol and hypertensive retinopathy: results of a cross-sectional study from Kanagawa Investigation of Total Checkup Data from the National Database-6 (KITCHEN-6).极高高密度脂蛋白胆固醇与高血压性视网膜病变的关联:来自全国数据库-6(KITCHEN-6)的横断面研究结果。
BMJ Open. 2021 May 11;11(5):e043677. doi: 10.1136/bmjopen-2020-043677.
5
An Age-Period-Cohort Analysis of Biomarkers of Lifestyle-Related Diseases Using the National Health and Nutrition Survey in Japan, 1973-2018.基于日本国民健康与营养调查 1973-2018 年数据的生活方式相关疾病生物标志物的年龄-时期-队列分析
Int J Environ Res Public Health. 2020 Nov 4;17(21):8159. doi: 10.3390/ijerph17218159.
6
Repositioning of the global epicentre of non-optimal cholesterol.非最佳胆固醇的全球中心位置的重新定位。
Nature. 2020 Jun;582(7810):73-77. doi: 10.1038/s41586-020-2338-1. Epub 2020 Jun 3.
7
National trends in total cholesterol obscure heterogeneous changes in HDL and non-HDL cholesterol and total-to-HDL cholesterol ratio: a pooled analysis of 458 population-based studies in Asian and Western countries.国家胆固醇总量趋势掩盖了高密度脂蛋白胆固醇和非高密度脂蛋白胆固醇以及总胆固醇与高密度脂蛋白胆固醇比值的异质性变化:亚洲和西方国家 458 项基于人群的研究的汇总分析。
Int J Epidemiol. 2020 Feb 1;49(1):173-192. doi: 10.1093/ije/dyz099.
8
High Incidence of Diabetes in People with Extremely High High-Density Lipoprotein Cholesterol: Results of the Kanagawa Investigation of Total Checkup Data from the National Database-1 (KITCHEN-1).极高密度脂蛋白胆固醇人群中糖尿病的高发病率:来自国家数据库 -1 的神奈川全面体检数据调查(KITCHEN -1)结果
J Clin Med. 2019 Mar 19;8(3):381. doi: 10.3390/jcm8030381.
9
Trend of HDL increase among Japanese people continues in National Health and Nutrition Survey.在国民健康与营养调查中,日本人高密度脂蛋白升高的趋势仍在持续。
J Atheroscler Thromb. 2018 Jun 1;25(6):554-556. doi: 10.5551/jat.43646. Epub 2018 Feb 2.
10
Bioinformatic Analysis of Plasma Apolipoproteins A-I and A-II Revealed Unique Features of A-I/A-II HDL Particles in Human Plasma.血浆载脂蛋白 A-I 和 A-II 的生物信息学分析揭示了人血浆中 A-I/A-II HDL 颗粒的独特特征。
Sci Rep. 2016 Aug 16;6:31532. doi: 10.1038/srep31532.